Supernus Pharmaceuticals (GB:0LB2)
LSE:0LB2

Supernus Pharmaceuticals (0LB2) Technical Analysis

0 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
4Neutral
4Bearish
Technical Analysis Consensus
Sell
2Bullish
4Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Supernus Pharmaceuticals’s (0LB2) Moving Averages Convergence Divergence (MACD) indicator is 0.97, suggesting Supernus Pharmaceuticals is a Sell.
Supernus Pharmaceuticals’s (0LB2) 20-Day exponential moving average is 28.86, while Supernus Pharmaceuticals’s (0LB2) share price is $30.71, making it a Buy.
Supernus Pharmaceuticals’s (0LB2) 50-Day exponential moving average is 28.33, while Supernus Pharmaceuticals’s (0LB2) share price is $30.71, making it a Buy.

Supernus Pharmaceuticals (0LB2) Pivot Points

Jul 27, 2024, 08:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
30.75
30.75
30.75
30.75
30.75
30.75
30.75
Fibonacci
30.75
30.75
30.75
30.75
30.75
30.75
30.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Supernus Pharmaceuticals (0LB2) Moving Averages

Jul 27, 2024, 08:38 AM
Period
Simple
Exponential
MA5
30.44Buy
30.40Buy
MA10
29.95Buy
29.78Buy
MA20
28.20Buy
28.86Buy
MA50
27.57Buy
28.33Buy
MA100
29.52Buy
28.61Buy
MA200
28.35Buy
28.49Buy
Supernus Pharmaceuticals’s (0LB2) 10-Day exponential moving average is 29.78, while Supernus Pharmaceuticals’s (0LB2) share price is $30.71, making it a Buy.
Supernus Pharmaceuticals’s (0LB2) 100-Day exponential moving average is 28.61, while Supernus Pharmaceuticals’s (0LB2) share price is $30.71, making it a Buy.
Supernus Pharmaceuticals’s (0LB2) stock price is $30.71 and Supernus Pharmaceuticals’s (0LB2) 50-day simple moving average is 27.57, creating a Buy signal.
Supernus Pharmaceuticals’s (0LB2) stock price is $30.71 and Supernus Pharmaceuticals’s (0LB2) 100-day simple moving average is 29.52, creating a Buy signal.
Supernus Pharmaceuticals’s (0LB2) stock price is $30.71 and Supernus Pharmaceuticals’s (0LB2) 200-day simple moving average is 28.35, creating a Buy signal.

Supernus Pharmaceuticals (0LB2) Technical Indicators

Jul 27, 2024, 08:38 AM
Name
Value
Implied Action
RSI (14)
68.59
Neutral
STOCH (9,6)
82.99
Sell
STOCHRSI (14)
92.42
Sell
MACD (12,26)
0.97
Sell
ADX (14)
35.50
Neutral
Williams %R
-4.74
Sell
CCI (14)
91.98
Neutral
ATR (14)
0.50
-
Ultimate Oscillator
63.79
Neutral
ROC
18.62
Buy
Supernus Pharmaceuticals’s (0LB2) Relative Strength Index (RSI) is 68.59, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Trend Strength Indicator (ADX) is 35.50, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Commodity Channel Index (CCI) is 91.98, creating a Neutral signal.
Supernus Pharmaceuticals’s (0LB2) Price Rate of Change (ROC) is 18.62, creating a Buy signal.

FAQ

Is 0LB2 a Buy, Hold, or Sell?
Based on 0LB2’s technical indicators, 0LB2 is a Buy.
    What is 0LB2’s RSI (14)?
    0LB2’s RSI (14) is 68.59, which suggests 0LB2 is a Neutral.
      What is 0LB2’s MACD?
      0LB2’s MACD is 0.97, which suggests 0LB2 is a Sell.
        What is 0LB2’s 5-day moving average?
        0LB2’s 5-day moving average is 30.44, which suggests 0LB2 is a Buy.
          What is 0LB2’s 20-day moving average?
          0LB2 20-day moving average is 28.20, which suggests 0LB2 is a Buy.
            What is 0LB2’s 50-day moving average?
            0LB2’s 50-day moving average is 27.57, which suggests 0LB2 is a Buy.
              What is 0LB2’s 200-day moving average?
              0LB2’s 200-day moving average is 28.35, which suggests 0LB2 is a Buy.
                What is 0LB2’s Williams % R (14)?
                0LB2’s Williams % R (14) is -4.74, which suggests 0LB2 is a Sell.
                  What is 0LB2’s CCI (14)?
                  0LB2’s CCI (14) is 91.98, which suggests 0LB2 is a Neutral.
                    What is the share price of Supernus Pharmaceuticals?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis